Sugi Predict

Sugi Predict / Compounds / SCHEMBL1335102

SCHEMBL1335102

SCHEMBL1335102

[O-][n+]1cc2ncn(CCCCO)c2c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 1/20 0.37
▸ CSNK2B P67870 1/20 0.37
▸ CSNK2A1 P68400 1/20 0.37
▸ CSNK2A3 Q8NEV1 1/20 0.37
▸ MPO P05164 2/20 0.36
▸ LMNA P02545 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PRKD3 O94806 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ FRK P42685 1/20 0.34
▸ MAPK9 P45984 1/20 0.34
▸ CSNK1A1 P48729 1/20 0.34
▸ CSNK1D P48730 1/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ PRKD2 Q9BZL6 1/20 0.34
▸ MAP4K5 Q9Y4K4 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9602275 0.91 DPP4 (0.41) LMNASMN1; SMN2POLBCYP1A2DPP4
SCHEMBL9601900 0.86 NR1I2 (0.41) SMN1; SMN2MAOAMAOBGRIN1GRIN2A
SCHEMBL10587329 0.86 NR1I2 (0.41) SMN1; SMN2MAOAMAOBGRIN1GRIN2A
SCHEMBL10588936 0.85 ALDH1A1 (0.41) MPOLMNAPOLBNPSR1KDM4E
SCHEMBL10727327 0.82 TLR7 (0.36) LMNASMN1; SMN2TSHRPOLBNPSR1
SCHEMBL4148302 0.81 TBXAS1 (0.45) LMNASMN1; SMN2CYP1A2CYP2C19NPSR1
SCHEMBL9603139 0.81 POLB (0.40) LMNASMN1; SMN2TSHRPOLBMAPK1
SCHEMBL4152469 0.81 NPSR1 (0.45) LMNASMN1; SMN2POLBCYP1A2CYP2C9
SCHEMBL9602609 0.80 HTT (0.51) TSHRHTTKMT2A
SCHEMBL10739313 0.80 TLR7 (0.49) LMNAPOLBNPSR1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2341933-B1 LIPIDATED IMIDAZOQUINOLINE DERIVATIVES GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2017-11-22 — — EP disclosed
US-8946421-B2 Lipidated imidazoquinoline derivatives GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) 2015-02-03 — — US disclosed
US-20140323731-A1 LIPIDATED IMIDAZOQUINOLINE DERIVATIVES GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) 2014-10-30 — — US disclosed
US-8624029-B2 Lipidated imidazoquinoline derivatives GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) 2014-01-07 — — US disclosed
US-20110282061-A1 Lipidated Imidazoquinoline Derivatives GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2011-11-17 — — US disclosed
EP-2341933-A1 LIPIDATED IMIDAZOQUINOLINE DERIVATIVES GlaxoSmithKline Biologicals SA (BE) 2011-07-13 — — EP disclosed
WO-2010048520-A1 LIPIDATED IMIDAZOQUINOLINE DERIVATIVES GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2010-04-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323731-A1 LIPIDATED IMIDAZOQUINOLINE DERIVATIVES IFNG, IRF3, IFNAR1 CSNK2A2 444/4885CSNK2B 819/4885CSNK2A1 369/4885
US-20110282061-A1 Lipidated Imidazoquinoline Derivatives IFNG, IRF3, IFNAR1 CSNK2A2 446/4885CSNK2B 823/4885CSNK2A1 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.